Paediatric inflammatory multisystem syndrome - temporally associated with SARS-CoV-2 (PIMS-TS) - a German single centre real-life evaluation of the Swiss and UK consensus statements.

Published in: Cardiology in the young (2022)

The Swiss and UK consensus statements on the management of PIMS-TS proved very valuable in a real-life clinical setting, facilitated early categorisation, and initiation of specific therapy, possibly improving the outcome. Additional randomised trials are necessary to further improve the management of PIMS-TS.

Keyphrases

sars cov
clinical trial
emergency department
cross sectional
clinical practice
oxidative stress
open label
stem cells
study protocol
randomized controlled trial
case report
respiratory syndrome coronavirus
bone marrow
cell therapy